ask="1.0500"
ask_size="4800"
average_daily_volume="575158"
bid="N/A"
bid_size="N/A"
book_value="0.6320"
change="-0.0249"
change_from_200_day_moving_average="0.0532"
change_from_50_day_moving_average="-0.0137"
change_from_52_week_high="-0.8548"
change_From_52_week_low="0.2341"
change_in_percent="-4.2203%"
close="0.5651"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6720"
ebitda="-18.47M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29692000"
high="0.5764"
high_52_weeks="1.4199"
last_trade_date="2/27/2017"
last_trade_price="0.5651"
last_trade_size="1295"
last_trade_time="4:00pm"
low="0.5354"
low_52_weeks="0.3310"
market_capitalization="17.00M"
moving_average_200_day="0.5119"
moving_average_50_day="0.5788"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5505"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+10.3901%"
percent_change_from_50_day_moving_average="-2.3710%"
percent_change_from_52_week_high="-60.2014%"
percent_change_from_52_week_low="+70.7251%"
previous_close="0.5900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.9335"
price_per_sales="3.5067"
revenue="5.06M"
shares_outstanding="30086000"
short_ratio="1.1100"
stock_exchange="NCM"
symbol="OGXI"
volume="180361"
weeks_range_52="0.3310 - 1.4199"
